Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc.'s SEC filings document financial results, operating updates, governance matters, and public-company disclosures for its beverage brand portfolio. Form 8-K reports include quarterly and annual results, guidance updates, Regulation FD disclosures, and other material events related to the company’s coconut water and better-for-you beverage operations.
Proxy materials describe annual meeting proposals, board structure, committee assignments, executive compensation, equity awards, and stockholder voting matters. Additional 8-K filings record director appointments, board retirements, officer roles, compensation arrangements, tariff-related disclosures, and the company’s capital-market reporting obligations as a Nasdaq-listed Delaware corporation.
Company: COCO. This Form 144 notifies proposed sales of common stock by Martin F. Roper and a brokerage holder. The excerpt lists multiple sale dates in April 2026, including repeated 25,000-share transactions and one 4,456-share transaction, with reported proceeds per line. The sales are reported as cash transactions and an option-derived sale appears dated 09/19/2019 (granted).
Martin F. Roper reported proposed and recent sales of Common Stock on Form 144. The filing lists multiple 25,000-share transactions in April 2026 priced around $1,250,000 each and a 4,456-share sale for $225,248.13. The securities include an option granted 09/19/2019.
COCO filed a Form 144 disclosing proposed and recent sales of Common Stock by Martin F. Roper. The filing lists an intended sale of 25,000 shares on 04/24/2026 (option granted 09/19/2019) with cash proceeds. The filing also reports multiple completed dispositions in April 2026, including 25,000 shares for $1,250,000 on 04/07/2026 and other dated sales through 04/16/2026.
The Vita Coco Company, Inc. filed an amended current report to update the responsibilities of recently appointed director Shelley Broader. She joined the Board on January 7, 2026, and on April 17, 2026, the Board appointed her to the Audit Committee and the Compensation Committee.
Her committee service will be effective June 3, 2026, following the Company’s 2026 Annual Meeting of Stockholders. The filing is signed by Chief Executive Officer Martin Roper on behalf of the Company.
The Vita Coco Company, Inc. is asking stockholders to vote at its virtual 2026 Annual Meeting on June 3, 2026 at 9:00 a.m. Eastern Time. Stockholders will elect three Class II directors to serve until 2029, ratify Deloitte & Touche LLP as auditor for 2026, and cast an advisory vote on executive compensation.
Holders of 56,983,327 common shares outstanding as of April 7, 2026 are entitled to one vote per share. The Board recommends voting FOR all three proposals. In its performance review, the company reports 2025 net sales of $610 million, up 18% or $94 million, adjusted EBITDA of $98 million versus $84 million in 2024, and net income of $71 million, or $1.19 per diluted share, compared with $0.94 per diluted share a year earlier. The year-end 2025 stock price was $53.01, about 44% higher than at the start of 2025. The proxy also describes the company’s classified board structure, committee memberships, auditor fees, and pay-for-performance philosophy that links a significant portion of executive pay to revenue, adjusted EBITDA and long-term equity incentives, with an ESG modifier added since 2023.
Wasatch Advisors reported beneficial ownership of 3,675,489 shares of Vita Coco Co Inc/The common stock, representing 6.4% of the class. The filing shows Wasatch has sole dispositive power over 3,675,489 shares and sole voting power for 2,489,521 shares. The disclosure is signed by CEO Mike Yeates.
Vita Coco Company, Inc. director and Chief Executive Officer Martin Roper reported an option exercise and related share sale. He exercised a non-qualified stock option to acquire 25,000 shares of common stock at $10.178 per share, then sold 25,000 shares of common stock at $50.00 per share in an open-market transaction effected under a Rule 10b5-1 trading plan.
Following these transactions, he directly holds 298,484 shares of common stock and retains multiple non-qualified stock options over additional shares with exercise prices between $10.178 and $32.78 expiring between 2031 and 2035. He also has indirect ownership of common stock through the Christopher G. Roper, Peter S. Roper, and Thomas L. Roper Exempt Family Trusts and through his spouse.
Vita Coco Company, Inc. CEO Martin Roper exercised stock options and sold shares in a planned set of trades. He exercised 25,000 non-qualified stock options at an exercise price of $10.178 per share on each of two days, receiving 50,000 shares of common stock.
On those same days he sold 25,000 shares at $50.00 and 25,000 shares at a weighted average price of $50.107, with actual sale prices ranging from $50.00 to $50.30, under a Rule 10b5-1 trading plan. After these transactions, he directly owns 298,484 common shares and continues to hold multiple option awards with exercise prices between $10.178 and $32.780, as well as indirect holdings through family trusts and his spouse.
Vita Coco Company, Inc. director Kenneth Sadowsky sold shares in a pre-planned trade. He sold 3,900 shares of common stock on April 15, 2026 in an open-market sale at a weighted average price of $48.93 per share under a Rule 10b5-1 trading plan.
After this sale, he directly owns 586,566 common shares and holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares at an exercise price of $10.178 per share, expiring on January 2, 2030.